Emerald Mutual Fund Advisers Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-107
| Closed | -$112K | – | 235 |
|
2024
Q3 | $112K | Hold |
107
| – | – | 0.01% | 217 |
|
2024
Q2 | $112K | Sell |
107
-50
| -32% | -$52.6K | 0.01% | 211 |
|
2024
Q1 | $151K | Sell |
157
-5
| -3% | -$4.81K | 0.01% | 204 |
|
2023
Q4 | $142K | Buy |
162
+22
| +16% | +$19.3K | 0.01% | 228 |
|
2023
Q3 | $115K | Buy |
140
+52
| +59% | +$42.8K | 0.01% | 217 |
|
2023
Q2 | $63.2K | Buy |
+88
| New | +$63.2K | ﹤0.01% | 237 |
|
2020
Q4 | – | Sell |
-153
| Closed | -$86K | – | 314 |
|
2020
Q3 | $86K | Buy |
+153
| New | +$86K | ﹤0.01% | 262 |
|